96 related articles for article (PubMed ID: 11159510)
1. Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes.
Nichols WG; Corey L; Gooley T; Drew WL; Miner R; Huang M; Davis C; Boeckh M
Blood; 2001 Feb; 97(4):867-74. PubMed ID: 11159510
[TBL] [Abstract][Full Text] [Related]
2. Multicenter comparison of the digene hybrid capture CMV DNA assay (version 2.0), the pp65 antigenemia assay, and cell culture for detection of cytomegalovirus viremia.
Mazzulli T; Drew LW; Yen-Lieberman B; Jekic-McMullen D; Kohn DJ; Isada C; Moussa G; Chua R; Walmsley S
J Clin Microbiol; 1999 Apr; 37(4):958-63. PubMed ID: 10074509
[TBL] [Abstract][Full Text] [Related]
3. Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies.
Xuan L; Huang F; Fan Z; Zhou H; Zhang X; Yu G; Zhang Y; Liu C; Sun J; Liu Q
J Hematol Oncol; 2012 Aug; 5():46. PubMed ID: 22856463
[TBL] [Abstract][Full Text] [Related]
4. Differences of cytomegalovirus diseases between kidney and hematopoietic stem cell transplant recipients during preemptive therapy.
Kim T; Lee YM; Lee SO; Choi SH; Kim YS; Woo JH; Sung H; Jung JH; Shin S; Kim YH; Kang YA; Lee YS; Lee JH; Lee JH; Lee KH; Park SK; Han DJ; Kim SH
Korean J Intern Med; 2016 Sep; 31(5):961-70. PubMed ID: 27055664
[TBL] [Abstract][Full Text] [Related]
5. Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplants.
Meijer E; Boland GJ; Verdonck LF
Clin Microbiol Rev; 2003 Oct; 16(4):647-57. PubMed ID: 14557291
[TBL] [Abstract][Full Text] [Related]
6. Comparison of valganciclovir
Zhu J; Xu M; Ru Y; Gong H; Ding Y; Zhu Z; Xu Y; Fan Y; Zhang X; Tu Y; Sun A; Qiu H; Jin Z; Tang X; Han Y; Fu C; Chen S; Ma X; Chen F; Song T; Wu D; Chen J
Leuk Lymphoma; 2024 Jun; 65(6):816-824. PubMed ID: 38475670
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of Double-Stranded DNA Viremia After Allogeneic Hematopoietic Cell Transplantation.
Hill JA; Mayer BT; Xie H; Leisenring WM; Huang ML; Stevens-Ayers T; Milano F; Delaney C; Jerome KR; Zerr DM; Nichols G; Boeckh M; Schiffer JT
Clin Infect Dis; 2018 Jan; 66(3):368-375. PubMed ID: 29020348
[TBL] [Abstract][Full Text] [Related]
8. Retrospective Evaluation of Cystatin C as a Measure of Renal Function in Pediatric Hematopoietic Stem Cell Transplant Patients Receiving Foscarnet for Cytomegalovirus Reactivation.
Pickett LR; Daukshus NP; Camacho-Bydume C; Mathew S; Mauguen A; Cohen N; Cancio M
Pediatr Infect Dis J; 2024 May; 43(5):457-462. PubMed ID: 38190640
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus Viral Load Threshold to Guide Preemptive Therapy in Hematopoietic Cell Transplant Recipients: Correlation With Cytomegalovirus Disease.
Sadowska-Klasa A; Leisenring WM; Limaye AP; Boeckh M
J Infect Dis; 2024 May; 229(5):1435-1439. PubMed ID: 37682870
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study.
Green ML; Leisenring W; Xie H; Mast TC; Cui Y; Sandmaier BM; Sorror ML; Goyal S; Özkök S; Yi J; Sahoo F; Kimball LE; Jerome KR; Marks MA; Boeckh M
Lancet Haematol; 2016 Mar; 3(3):e119-27. PubMed ID: 26947200
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of coexisting HCMV-UL97 and UL54 drug-resistance associated mutations in patients after haematopoietic cell transplantation.
Göhring K; Wolf D; Bethge W; Mikeler E; Faul C; Vogel W; Vöhringer MC; Jahn G; Hamprecht K
J Clin Virol; 2013 May; 57(1):43-9. PubMed ID: 23375740
[TBL] [Abstract][Full Text] [Related]
12. Emerging concepts in cytomegalovirus infection following hematopoietic stem cell transplantation.
Camargo JF; Komanduri KV
Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):233-238. PubMed ID: 28641094
[TBL] [Abstract][Full Text] [Related]
13. Refractory cytomegalovirus infections in Chinese patients receiving allogeneic hematopoietic cell transplantation: a review of the literature.
Yang D; Yao Y; Sun Y; Jiang E
Front Immunol; 2023; 14():1287456. PubMed ID: 38187387
[TBL] [Abstract][Full Text] [Related]
14. Updates in Cytomegalovirus Prevention and Treatment in Solid Organ Transplantation.
Doss KM; Heldman MR; Limaye AP
Infect Dis Clin North Am; 2023 Nov; ():. PubMed ID: 37989636
[TBL] [Abstract][Full Text] [Related]
15. Virus-Specific T Cells: Promising Adoptive T Cell Therapy Against Infectious Diseases Following Hematopoietic Stem Cell Transplantation.
Jalili A; Hajifathali A; Mohammadian M; Sankanian G; Sayahinouri M; Dehghani Ghorbi M; Roshandel E; Aghdami N
Adv Pharm Bull; 2023 Jul; 13(3):469-482. PubMed ID: 37646062
[TBL] [Abstract][Full Text] [Related]
16. How to improve the outcomes of elderly acute myeloid leukemia patients through allogeneic hematopoietic stem cell transplantation.
Jiang S; Yan H; Lu X; Wei R; Chen H; Zhang A; Shi W; Xia L
Front Immunol; 2023; 14():1102966. PubMed ID: 37207218
[TBL] [Abstract][Full Text] [Related]
17. Another tool against cytomegalovirus after allogeneic hematopoietic cell transplantation.
Chen GL; Shpall EJ
J Clin Invest; 2023 May; 133(10):. PubMed ID: 37183817
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of Refractory Cytomegalovirus Infection in the First Year after Allogeneic Hematopoietic Cell Transplantation.
Karantoni E; Zavras PD; Su Y; Fang J; Tamari R; Cho C; Perales MA; Stern A; Papanicolaou GA
Transplant Cell Ther; 2022 Jul; 28(7):403.e1-403.e7. PubMed ID: 35476955
[TBL] [Abstract][Full Text] [Related]
19. A Predicted Model for Refractory/Recurrent Cytomegalovirus Infection in Acute Leukemia Patients After Haploidentical Hematopoietic Stem Cell Transplantation.
Shen MZ; Hong SD; Wang J; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YH; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ; Mo XD
Front Cell Infect Microbiol; 2022; 12():862526. PubMed ID: 35392613
[TBL] [Abstract][Full Text] [Related]
20. Mathematical Modeling of Within-Host, Untreated, Cytomegalovirus Infection Dynamics after Allogeneic Transplantation.
Duke ER; Boshier FAT; Boeckh M; Schiffer JT; Cardozo-Ojeda EF
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
